The effect of injectable iron on blood transfusion rate in patients with hip fractures

Evaluation of allogeneic transfusion after injection of injectable iron in patients’ candidates for intertrochanteric fracture surgery

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190121042444N4

Enrollment

Registered

2021-10-20

Start date

2021-09-22

Completion date

Unknown

Last updated

2021-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Femoral fractures. Intertrochanteric fracture

Interventions

Intervention 1: Intervention group: The group will be monitored by a specific orthopedic professor under the treatment protocol of intertrochantric fracture treatment center of Shohada Tajrish Hospit

Eligibility

Sex/Gender

All

Age

65 Years to 90 Years

Inclusion criteria

Inclusion criteria: Intertrochanteric fractures Age over 65 years

Exclusion criteria

Exclusion criteria: Excessive iron disorders Other anemic disorders due to diseases such as thalassemia Chronic Diseases Megaloblastic anemia Sensitivity to oral or injectable iron Treatment of asthma with clopidogrel or with salicylic acetyl Blood coagulation disorders Liver diseases Hypothyroidism or hyperthyroidism Chronic renal failure

Design outcomes

Primary

Measure	Time frame
Bleeding volume. Timepoint: Before the intervention and during surgery. Method of measurement: Based on measurements of the surgical field and the volume of suction.;Number of PRBC received. Timepoint: Before the intervention and during surgery. Method of measurement: Number of blood bags injected.;Hemoglobin. Timepoint: Before intervention and 1 hour after surgery and 7 days after surgery. Method of measurement: Measurement of serum levels in a blood test.;Hematocrit. Timepoint: Before intervention and 1 hour after surgery and 7 days after surgery. Method of measurement: Measurement of serum levels in a blood test.;Ferritin. Timepoint: Before intervention and 1 hour after surgery and 7 days after surgery. Method of measurement: Measurement of serum levels in a blood test.;Reticulocytes. Timepoint: Before intervention and 1 hour after surgery and 7 days after surgery. Method of measurement: Measurement of serum levels in a blood test.;Red blood cell count. Timepoint: Before intervention and 1 hour after surgery and 7 days after surgery. Method of measurement: Measure the number in the blood test.;Iron level. Timepoint: Before intervention and 1 hour after surgery and 7 days after surgery. Method of measurement: Measurement of serum levels in a blood test.	—

Measure

Time frame

Bleeding volume. Timepoint: Before the intervention and during surgery. Method of measurement: Based on measurements of the surgical field and the volume of suction.;Number of PRBC received. Timepoint: Before the intervention and during surgery. Method of measurement: Number of blood bags injected.;Hemoglobin. Timepoint: Before intervention and 1 hour after surgery and 7 days after surgery. Method of measurement: Measurement of serum levels in a blood test.;Hematocrit. Timepoint: Before intervention and 1 hour after surgery and 7 days after surgery. Method of measurement: Measurement of serum levels in a blood test.;Ferritin. Timepoint: Before intervention and 1 hour after surgery and 7 days after surgery. Method of measurement: Measurement of serum levels in a blood test.;Reticulocytes. Timepoint: Before intervention and 1 hour after surgery and 7 days after surgery. Method of measurement: Measurement of serum levels in a blood test.;Red blood cell count. Timepoint: Before intervention and 1 hour after surgery and 7 days after surgery. Method of measurement: Measure the number in the blood test.;Iron level. Timepoint: Before intervention and 1 hour after surgery and 7 days after surgery. Method of measurement: Measurement of serum levels in a blood test.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFaranak Behnaz

Shahid Beheshti University of Medical Sciences

faranak.behnaz@gmail.com+98 21 2274 1174

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026